Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saakshi Medtech and PanelsNSE:SAAKSHI -1.43%50 ROA % is 7.85% as of Mar. 2026, which is 22% below its 10-year median of 10.10. GuruFocus rates NSE:SAAKSHI with a GF Score™ of 50/100 and a GF Value™ of ₹220.57 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 3,085 Industrial Products companies, Saakshi Medtech and Panels ranks better than 55.24% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Saakshi Medtech and Panels's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹113.2 Mil.
Saakshi Medtech and Panels's average Total Assets over the quarter that ended in Mar. 2026 was ₹1,441.6 Mil. Therefore, Saakshi Medtech and Panels's annualized ROA % for the quarter that ended in Mar. 2026 was 7.85%.
The historical rank and industry rank for Saakshi Medtech and Panels's ROA % or its related term are showing as below:
NSE:SAAKSHI'
s ROA % Range Over the Past 10 Years
Min: 3.6 Med: 10.1 Max: 15.62
Current: 3.93
During the past 7 years, Saakshi Medtech and Panels's highest ROA % was 15.62%. The lowest was 3.60%. And the median was 10.10%.
NSE:SAAKSHI's ROA % is ranked better than 55.24% of 3085
companies
in the Industrial Products industry
Industry Median: 3.19
vs NSE:SAAKSHI: 3.93
Saakshi Medtech and Panels (NSE:SAAKSHI) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Electrical Equipment & Parts subindustry, Saakshi Medtech and Panels's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saakshi Medtech and Panels ROA % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Saakshi Medtech and Panels's ROA % distribution charts can be found below:
* The bar in red indicates where Saakshi Medtech and Panels's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Saakshi Medtech and Panels (NSE:SAAKSHI) has a ROA % of 7.85% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Saakshi Medtech and Panels and its competitors. This is 22% below median its historical median of 10.10. Over the past decade, Saakshi Medtech and Panels' ROA % has ranged from 3.60 to 15.62. According to the industry distribution chart, Saakshi Medtech and Panels ranks #1381 out of 3085 companies in the Industrial Products industry, placing it in the top 44.8%.
Is Saakshi Medtech and Panels' ROA % too high?
Saakshi Medtech and Panels' current ROA % of 7.85% is 22% below median its 10-year median of 10.10. Over the past 10 years, this metric has ranged from a low of 3.60 to a high of 15.62. The Industrial Products industry median ROA % is 3.19. Saakshi Medtech and Panels' value of 7.85% is 146.1% above this industry median. Based on the distribution chart, Saakshi Medtech and Panels ranks #1381 out of 3085 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Saakshi Medtech and Panels has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Saakshi Medtech and Panels' ROA % compare to VRT and BE?
According to the Industrial Products industry distribution chart, Saakshi Medtech and Panels ranks #1381 out of 3085 companies for ROA %. This puts Saakshi Medtech and Panels in the upper half of its industry. The industry median ROA % is 3.19. Saakshi Medtech and Panels' value of 7.85% is 146.1% above this benchmark. Historically, Saakshi Medtech and Panels' own ROA % has ranged from 3.60 to 15.62 over the past decade. While the company's 10-year median is 10.10 vs. the industry median of 3.19, Saakshi Medtech and Panels has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for an Industrial Products company?
The median ROA % among Industrial Products companies is 3.19, based on 3,085 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saakshi Medtech and Panels's current ROA % of 7.85% is 146.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Saakshi Medtech and Panels and its competitors. For the Industrial Products industry, the median ROA % is 3.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saakshi Medtech and Panels's current ROA % is 7.85%, which is 22% below median its own 10-year median of 10.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saakshi Medtech and Panels stock overvalued right now?
Based on GuruFocus' analysis, Saakshi Medtech and Panels (NSE:SAAKSHI) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹220.57, compared to a current price of ₹345.40 — trading 56.6% above its estimated fair value. The current ROA % is 7.85%, which is 22% below median its 10-year median of 10.10 and 146.1% above the Industrial Products industry median of 3.19. Saakshi Medtech and Panels' overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Saakshi Medtech and Panels (NSE:SAAKSHI), the current ROA % is 7.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saakshi Medtech and Panels (NSE:SAAKSHI) Overvalued in 2026?
Based on GuruFocus' analysis, Saakshi Medtech and Panels stock appears to be overvalued.
The current stock price of ₹345.40 is trading 56.6% above its estimated GF Value™ of ₹220.57.
GuruFocus considers Saakshi Medtech and Panels to be Significantly Overvalued.
Key valuation signals for NSE:SAAKSHI:
ROA %: 7.85% (22% below median its 10-year median of 10.10)
GF Value™: ₹220.57 vs. price of ₹345.40 (56.6% above fair value)
Industry Position: 146.1% above the Industrial Products median (#1381 of 3085)
No single metric tells the full story. See the NSE:SAAKSHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saakshi Medtech and Panels Ltd is a diversified company engaged in manufacturing Electrical Control Panels and Cabinets used in elevators, air compressors, renewable energy industry, oil & gas exploration industry, electrical vehicle charging stations, medical X-Ray Systems used in healthcare industry, fabrication works for locomotives, and wire harness division for their captive consumption in electrical control panels and for supply to air compressor industry. Their comprehensive solutions include design, process engineering, and manufacturing including fabrication, assembly, and testing facilities. It designs, programs, and assembles Electrical Control Panels and Cabinets comprising microcontrollers, programmable logic controllers, and SCADA systems.
50GF Score
Get the complete analysis for NSE:SAAKSHI
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAAKSHI has been successfully added to your 
